Elsevier’s ClinicalKey Now accelerates access to localised clinical guidelines and content for clinicians at the point of care

Elsevier, a global leader in evidence-based clinical practice content, research publishing and information analytics, today announces the launch of ClinicalKey Now, a mobile interactive discovery tool that enables clinicians in India to access accurate, concise, and actionable evidence-based information to support diagnosis and treatment of patients. Curated and peer-reviewed by expert physicians in India, the tool adheres to global practice standards while aligning with local and regional clinical guidelines. As a mobile-first tool, ClinicalKey Now facilitates physicians’ access to medical content with ease and convenience at the point of care.

One of the most pressing challenges in Indian healthcare is the unequal distribution of resources, highlighted by high patient-to-clinician ratios and limited access to quality healthcare. According to the World Health Organisation (WHO), the clinician-to-patient ratio in India is 1:1700 against the 1:1000 recommendation¹. This can put a strain on clinicians, who may have to spend a significant amount of time on administrative responsibilities. This can leave clinicians with little to no time to spend with their patients, which can then impact the quality of care that they are able to provide². To address these challenges, clinicians can leverage technology, such as ClinicalKey Now, to free up clinicians' time so that they can focus on providing care to their patients even in the remotest areas of the country.

ClinicalKey Now helps support physicians in the medical diagnosis and treatment process through its intuitive clinical algorithms, offering summarised practical steps for the management of patient conditions. It also contains a visual map that traces and maps symptoms to treatment methods. This intuitive user journey, all-optimised for a mobile experience, empowers physicians to find accurate answers within seconds, even when offline or in rural remote areas, in-between, or during patient consultations.

Shanker Kaul, Managing Director, India, Elsevier, said: “Due to the ever-increasing workload on medical practitioners, changing patient needs and barriers to accessing the latest verified information, physicians in India find it challenging to stay on top of advances in medicine. It is important for physicians to have access to tools that can help them to diagnose more accurately and prescribe more effective treatment plans that are in line with the Indian healthcare system, to manage common diseases and conditions within our population. ClinicalKey Now allows clinicians quick access to easily actionable and localised recommendations, reducing the time required for them to retrieve information to provide informed care to patients.”

ClinicalKey Now features longer form synoptic content inclusive of clinical reviews and offers comprehensive information and drug monographs, with coverage of approved combination therapies and availability of treatment in India. In addition, ClinicalKey Now provides concise answers through intuitive search to support physicians when diagnosing and treating patients ​wherever clinicians are practicing. This allows clinicians to spend more time supporting patients which in turn enables a streamlined workflow and helps improve the quality of care administered.

¹ Leveraging AI in the Indian healthcare system: Opportunities and challenges 新しいタブ／ウィンドウで開く, Business Insider India, 30 June 2022

² Enabling healthcare with technology 新しいタブ／ウィンドウで開く, PwC & BCC&I, March 2023

---

エルゼビアについて

エルゼビアは情報分析を専門としたグローバル企業として、研究者や医療専門家の方々を支援し、社会にとっての利益最大化に向けて、科学や医療の進展を支えています。これは、信頼できるエビデンスによるコンテンツと高度なAI対応によるデジタル技術に基づく革新的なソリューションにより、知見の集積や重要な意思決定を支援することで実現されています。

エルゼビアは、全世界で9,700人の従業員（うち技術者2,300人以上）を抱え、140年以上にわたって、研究者、図書館員、アカデミックリーダー、資金提供者、政府、研究開発集約型企業、医師、看護師、将来の医療専門家、教育者など研究・医療分野におけるパートナーの重要な活動を支援してきました。エルゼビアが刊行する3,000誌以上の科学ジャーナルと代表的な参考書には、The Lancet 新しいタブ／ウィンドウで開く、Cell Press 新しいタブ／ウィンドウで開くおよびGray’s Anatomyなどをはじめとする、各分野を代表する主要なタイトルが含まれています。 エルゼビア・ファンデーション 新しいタブ／ウィンドウで開くとの活動を通し、私たちがサービスを提供する地域社会と連携して、開発途上国を含む世界中の医学、研究、医療分野における、インクルージョン＆ダイバーシティ（I&D）の改善に努めています。

エルゼビアは、専門家および企業向けの情報分析および意思決定ツールのグローバルプロバイダーであるRELX Group 新しいタブ／ウィンドウで開くの一事業を担っています。エルゼビアの事業内容、デジタルソリューション、コンテンツなどの詳細については、www.elsevier.comをご覧ください。